Beta Cat Pharmaceuticals, Inc. — Form D

Beta Cat Pharmaceuticals, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-08. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Kenneth C CarterDirectorSYKESVILLE, MD
Jonathan P NorthrupDirectorGaithersburg, MD
Sunil C SharmaDirectorGaithersburg, MD
Alain C CappelutiExecutive OfficerGaithersburg, MD
Jonathan P NorthrupExecutive OfficerGaithersburg, MD
Sunil C SharmaExecutive OfficerGaithersburg, MD
James EadieDirectorArden Hills, MN
Sunil P SharmaDirectorDallas, TX
Sunil P SharmaExecutive OfficerDallas, TX
Sunil SharmaDirectorVancouver, A1
Sunil SharmaExecutive OfficerVancouver, A1
Joseph CunninghamDirectorSunrise, FL
Joe CunninghamDirectorAUSTIN, TX
Kenneth CarterDirectorSAN FRANCISCO, CA
Scott JordanDirectorSandy, UT
Scott JordanExecutive OfficerSandy, UT
Jonathan NorthrupDirectorHouston, TX
Jonathan NorthrupExecutive OfficerHouston, TX
Rahul ArasExecutive OfficerCleveland, OH
Uma BhattExecutive OfficerHouston, TX
Kenneth P CarterDirectorHouston, TX
Joseph P CunninghamDirectorHouston, TX
Alain P CappelutiExecutive OfficerHouston, TX
Stephen P HorriganExecutive OfficerHouston, TX
Casey P CunninghamExecutive OfficerHouston, TX

Other filings by this issuer (3)

FiledFormOfferingSold
2018-06-27D$6.0M$2.6M
2017-12-18D$1.4M$1.4M
2015-07-02D$3.0M$1.0M

More